Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1Oligodendroglioma 1Kidney Neoplasms 1Hematologic Neoplasms 1HIV Infections 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3Specimen Handling 3Magnetic Resonance Spectroscopy 3interferon alfa-n1 2cabozantinib 2Nivolumab 2Cyclophosphamide 2Biopsy 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1ibrutinib 1fludarabine 1efineptakin alfa 1axicabtagene ciloleucel 1Zalcitabine 1Vorinostat 1Tumor Necrosis Factor-alpha 1Transplantation Conditioning 1Taxes 1Sunitinib 1Polymerase Chain Reaction 1Pentoxifylline 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × HIV Infections × Muromonab-CD3 × Clear all
NCT00001535 2008-02-08

Twins Study of Gene Therapy for HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
48 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡